Clin2
NCT06610422Possibly a fitNot yet recruiting

Nerve damage and antibodies in lupus patients

Lupus Nephritis

Part of Immune system & allergy, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.

This study looks at whether certain antibodies (proteins in your blood that fight infection but can sometimes attack your own body) are linked to nerve damage in people with lupus and kidney disease. If you join, researchers will check your blood for these antibodies and see how they relate to your symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
159 people
Ages
18 years to 80 years
Study type
Observational

Who can take part

  • You must be a woman aged 18 or older.
  • You need a lupus diagnosis with kidney involvement (lupus nephritis).
  • Your kidney function must be in stage 1 to 4 (not needing dialysis).
  • You must not have hepatitis B or C, cancer (except some skin cancers), or be on pulse steroid therapy.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07505576Not yet recruiting
Antibody test for lupus kidney disease activity

This study looks at whether a blood test for a specific antibody can help doctors understand how active lupus kidney disease is. It may help guide treatment decisions for people with lupus nephritis.

NCT05443516Recruiting
Blood and urine markers in active lupus kidney disease

This study looks at blood and urine markers that may show how active lupus kidney disease is and how it changes over time. It may help doctors better monitor people with active lupus-related kidney inflammation.

Brussels
NCT06167174Recruiting
Looking for markers to predict lupus kidney treatment response

This study is looking for biomarkers (clues in your blood, urine, or tissue) that can help predict how well lupus nephritis (kidney inflammation caused by lupus) responds to treatment. It focuses on people who have active kidney disease and are either starting treatment or have been on a stable treatment for at least a month.

Beijing
NCT07780045Not yet recruiting
Blood tests as markers for kidney disease in lupus patients

This study looks at whether simple blood tests can help doctors better understand and track kidney problems that occur in people with lupus. The goal is to see if these markers can predict how the disease will progress, which could help guide treatment.

NCT07666711Recruiting
Kidney biomarker study for lupus patients

This study aims to find better ways to detect kidney problems in people with lupus by testing blood and urine samples. If you have lupus, you may help researchers improve how kidney disease is diagnosed and monitored.

Oslo, Oslo
NCT07805863Not yet recruiting
Blood test for lupus activity

This study aims to see if a blood test that measures a specific protein-related molecule can help doctors know how active your lupus is. If successful, this could lead to a simpler way to monitor the disease and adjust treatment.

Hear when a new Lupus Nephritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.